Calcium dobesilate-induced agranulocytosis.
Here we report a case of a patient in whom the administration of calcium dobesilate was associated with the development of an agranulocytosis episode. Eight weeks after the beginning of the treatment he was hospitalized with fever and leucopenia. Bone marrow biopsy showed a maturative promyelocytic interruption. All medication was withdrawn and blood cell count was completely recovered 7 days after admission. G-CSF was administered. A detailed study was performed and causal relationship was not suggestive for the other three drugs the patient was receiving. To date, there have only been reported two cases of calcium dobesilate induced agranulocytosis.
García Benayas
E
E
Severo Ochoa Hospital, Madrid, Spain.
García Díaz
B
B
Pérez
G
G
D000380:Agranulocytosis / Q000139:chemically induced*; D002123:Calcium Dobesilate / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003930:Diabetic Retinopathy / Q000188:drug therapy / Q000209:etiology; D006490:Hemostatics / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged
D006490:Hemostatics; D002123:Calcium Dobesilate